PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EQNR vs. NVS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EQNR and NVS is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

EQNR vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Equinor ASA (EQNR) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-15.07%
-8.49%
EQNR
NVS

Key characteristics

Sharpe Ratio

EQNR:

-0.79

NVS:

0.13

Sortino Ratio

EQNR:

-0.96

NVS:

0.29

Omega Ratio

EQNR:

0.88

NVS:

1.04

Calmar Ratio

EQNR:

-0.61

NVS:

0.11

Martin Ratio

EQNR:

-1.57

NVS:

0.32

Ulcer Index

EQNR:

13.70%

NVS:

7.02%

Daily Std Dev

EQNR:

27.15%

NVS:

16.66%

Max Drawdown

EQNR:

-66.92%

NVS:

-41.72%

Current Drawdown

EQNR:

-33.95%

NVS:

-19.95%

Fundamentals

Market Cap

EQNR:

$63.17B

NVS:

$198.38B

EPS

EQNR:

$3.27

NVS:

$5.73

PE Ratio

EQNR:

6.94

NVS:

17.29

PEG Ratio

EQNR:

3.57

NVS:

2.95

Total Revenue (TTM)

EQNR:

$104.81B

NVS:

$49.29B

Gross Profit (TTM)

EQNR:

$35.07B

NVS:

$36.69B

EBITDA (TTM)

EQNR:

$42.63B

NVS:

$19.76B

Returns By Period

In the year-to-date period, EQNR achieves a -21.47% return, which is significantly lower than NVS's -0.50% return.


EQNR

YTD

-21.47%

1M

-6.00%

6M

-15.07%

1Y

-20.08%

5Y*

9.37%

10Y*

N/A

NVS

YTD

-0.50%

1M

-6.29%

6M

-8.48%

1Y

3.43%

5Y*

5.91%

10Y*

5.99%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EQNR vs. NVS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Equinor ASA (EQNR) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for EQNR, currently valued at -0.79, compared to the broader market-4.00-2.000.002.00-0.790.13
The chart of Sortino ratio for EQNR, currently valued at -0.96, compared to the broader market-4.00-2.000.002.004.00-0.960.29
The chart of Omega ratio for EQNR, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.04
The chart of Calmar ratio for EQNR, currently valued at -0.61, compared to the broader market0.002.004.006.00-0.610.11
The chart of Martin ratio for EQNR, currently valued at -1.57, compared to the broader market0.0010.0020.00-1.570.32
EQNR
NVS

The current EQNR Sharpe Ratio is -0.79, which is lower than the NVS Sharpe Ratio of 0.13. The chart below compares the historical Sharpe Ratios of EQNR and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00JulyAugustSeptemberOctoberNovemberDecember
-0.79
0.13
EQNR
NVS

Dividends

EQNR vs. NVS - Dividend Comparison

EQNR's dividend yield for the trailing twelve months is around 12.97%, more than NVS's 3.90% yield.


TTM20232022202120202019201820172016201520142013
EQNR
Equinor ASA
12.97%8.85%4.13%2.24%4.32%4.85%2.37%0.00%0.00%0.00%0.00%0.00%
NVS
Novartis AG
3.90%3.44%3.91%4.08%3.40%2.87%3.72%3.50%4.06%3.51%3.14%3.37%

Drawdowns

EQNR vs. NVS - Drawdown Comparison

The maximum EQNR drawdown since its inception was -66.92%, which is greater than NVS's maximum drawdown of -41.72%. Use the drawdown chart below to compare losses from any high point for EQNR and NVS. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-33.95%
-19.95%
EQNR
NVS

Volatility

EQNR vs. NVS - Volatility Comparison

Equinor ASA (EQNR) has a higher volatility of 9.86% compared to Novartis AG (NVS) at 4.69%. This indicates that EQNR's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%JulyAugustSeptemberOctoberNovemberDecember
9.86%
4.69%
EQNR
NVS

Financials

EQNR vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Equinor ASA and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab